Put companies on watchlist
Kenvue
ISIN: US49177J1025
WKN: A3EEHU
About
Company Snapshot
New: Enable Investor Alerts
Be informed about new publications
New: AI Factsheet

Corporate News meets AI! 
Content analysis and summary

Kenvue · ISIN: US49177J1025 · Business Wire (ID: 20240823569733)
23 August 2024 12:45PM

Kenvue Announces Participation in the Barclays Global Consumer Staples Conference


Kenvue Inc. (NYSE: KVUE) (“Kenvue”) today announced the Company’s participation in the Barclays Global Consumer Staples Conference in Boston, Massachusetts. Thibaut Mongon, Chief Executive Officer, Paul Ruh, Chief Financial Officer, and Charmaine England, Chief Growth Officer, will participate in a fireside chat on Thursday, September 5, 2024, at 3:00 p.m. Eastern Time. A live webcast of the session will be available on investors.kenvue.com and a replay will be available on the website following the event.

About Kenvue

Kenvue is the world’s largest pure-play consumer health company by revenue. Built on more than a century of heritage, our iconic brands, including Aveeno®, BAND-AID® Brand, Johnson’s®, Listerine®, Neutrogena® and Tylenol®, are science-backed and recommended by healthcare professionals around the world. At Kenvue, we believe in the extraordinary power of everyday care and our teams work every day to put that power in consumers’ hands and earn a place in their hearts and homes. Learn more at www.kenvue.com.

Contact

Investor Relations:
Jim Giannakouros, CFA
Kenvue_IR@Kenvue.com

Media Relations:
Melissa Witt
media@kenvue.com

Visual performance / price development - Kenvue
Smart analysis and research tools can be found here.
This publication was provided by our content partner Business Wire
BusinessWire
via BusinessWire - Newsfeed
BusinessWire ©2024
BusinessWire
Contact:
101 California Street, 20th Floor San Francisco, CA, 94111 United States
+1.415.986.4422